We Must All Be Equal Partners In The New Age Of Genetics

The Human Genome Project has transformed the field of human genetics into one that holds the most promise for technological discoveries in the new millennium. In his 1997 State of the Union address, President Clinton named the Human Genome Project first in a list of advances in medical science. In a subsequent speech, he called the next 50 years the "new age of biology," as science continues to unravel the mysteries of human existence. Genetic conditions affect all economic, social, and racial

Written byIlana Suez Mittman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The Human Genome Project has transformed the field of human genetics into one that holds the most promise for technological discoveries in the new millennium. In his 1997 State of the Union address, President Clinton named the Human Genome Project first in a list of advances in medical science. In a subsequent speech, he called the next 50 years the "new age of biology," as science continues to unravel the mysteries of human existence.

Genetic conditions affect all economic, social, and racial groups and impact on the health of family members for generations. It is evident that genetics plays a significant role in most common diseases, which places this discipline among the top medical priorities in advanced nations. Therefore, it's ironic that these technological advances have consistently failed to meet the needs of racial or ethnic minorities, who traditionally suffer from poorer health than do non-Hispanic whites. Moreover, communities of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies